EFX vs ISPC · P/E 54, rev $5.68B vs rev $9.3M
Equifax Inc (EFX) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the EFX and ISPC stock pages for the full models.
Not investment advice.